^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    utomilumab (PF-05082566)

    i
    Company:
    Novartis, Pfizer
    Drug class:
    CD137 agonist
    Related drugs: